跳至主要内容
临床试验/ISRCTN16902075
ISRCTN16902075进行中(未招募)2 期

A Mesh SAfety Platform for Immediate Implant-based BReAst Reconstruction (MAP-BRA) - Project 1. A multicentre prospective cohort study to evaluate the safety and effectiveness of Fortiva porcine acellular dermal matrix in immediate implant-based breast reconstruction

Royal Liverpool and Broadgreen University Hospital NHS Trust0 个研究点目标入组 79 人开始时间: 2020年1月14日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
79

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women over the age of 18 undergoing mastectomy for invasive or pre-invasive breast cancer or risk reduction
  • 2. Elect to undergo a sub-pectoral or pre-pectoral immediate implant-based reconstruction with mesh

排除标准

  • Patients undergoing:
  • 1. Revisional surgery
  • 2. Delayed breast reconstruction
  • 3. Previous breast or mantle radiotherapy
  • 4. Patients who are allergic to pork or unwilling to have a porcine product
  • 5. Patients unable or unwilling to give informed consent
  • 6. Patients considered by their surgeon to be unsuitable for mesh reconstruction
  • 7. Patients who currently smoke cigarettes or e-cigarettes
  • 8. Patients with a BMI of 35 or above
  • 9. Patients in whom it is anticipated that an implant volume of greater than 500cc will be required

研究者

发起方
Royal Liverpool and Broadgreen University Hospital NHS Trust

相似试验